Skip to main content

Articles

FDA Approvals
Nesina, Kazano, and Oseni: Three Alogliptin-Based Agents Approved for the Treatment of Type 2 Diabetes
Read More
FDA Approvals
Tafinlar and Mekinist: Two Oral Targeted Kinase Inhibitors for the Treatment of Patients with Metastatic Melanoma and BRAF Mutations
Read More
New Directions in the Treatment of Multiple Myeloma: Reports on Carfilzomib Therapy from ASCO 2013 and EHA 2013
Read More
Practice Management
FDA Expected to Approve Surrogate End Point for Neoadjuvant Breast Cancer Trials
Read More
Lung Cancer, Oncology
Crizotinib Superior to Standard Chemotherapy in ALK-Positive Lung Cancer
Read More
FDA Approvals
Xofigo (Radium Ra 223 Dichloride): The First Alpha Particle–Emitting Radioactive Agent for the Treatment of Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
Read More
Perspectives
Cancer Care in 2013: Hope, Reality, and a Call to Action
Read More
Experts Debate Value of Bevacizumab in Newly Diagnosed Glioblastoma
Read More
Bevacizumab an Effective New Treatment Option for Relapsed Cervical Cancer
Read More
Sorafenib Effective in Metastatic Differentiated Thyroid Cancer
Read More
Page 172 of 244
Results 1711 - 1720 of 2439